Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer

Rajnish A. Gupta, Jian Tan, Wade F. Krause, Mark W. Geraci, Timothy M. Willson, Sudhansu K. Dey, Raymond N. DuBois

Research output: Contribution to journalArticle

332 Citations (Scopus)

Abstract

There is evidence from both genetic and pharmacologic studies to suggest that the cyclooxygenase-2 (COX-2) enzyme plays a causal role in the development of colorectal cancer. However, little is known about the identity or role of the eicosanoid receptor pathways activated by COX-derived prostaglandins (PG). We previously have reported that COX-2-derived prostacyclin promotes embryo implantation in the mouse uterus via activation of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) δ. In light of the recent finding that PPARδ is a target of β-catenin transactivation, it is important to determine whether this signaling pathway is operative during the development of colorectal cancer. Analysis of PPARδ mRNA in matched normal and tumor samples revealed that expression of PPARδ, similar to COX-2, is up-regulated in colorectal carcinomas. In situ hybridization studies demonstrate that PPARδ is expressed in normal colon and localized to the epithelial cells at the very tips of the mucosal glands. In contrast, expression of PPARδ mRNA in colorectal tumors was more widespread with increased levels in transformed epithelial cells. Analysis of PPARδ and COX-2 mRNA in serial sections suggested they were colocalized to the same region within a tumor. Finally, transient transfection assays established that endogenously synthesized prostacyclin (PGI2) could serve as a ligand for PPARδ. In addition, the stable PGI2 analog, carbaprostacyclin, and a synthetic PPARδ agonist induced transactivation of endogenous PPARδ in human colon carcinoma cells. We conclude from these observations that PPARδ, similar to COX-2, is aberrantly expressed in colorectal tumors and that endogenous PPARδ is transcriptionally responsive to PGI2. However, the functional consequence of PPARδ activation in colon carcinogenesis still needs to be determined.

Original languageEnglish (US)
Pages (from-to)13275-13280
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number24
DOIs
StatePublished - Nov 21 2000
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Epoprostenol
Colorectal Neoplasms
Cyclooxygenase 2
Colon
Messenger RNA
Transcriptional Activation
Eicosanoid Receptors
Epithelial Cells
Catenins
Cytoplasmic and Nuclear Receptors
Uterus
Prostaglandins
In Situ Hybridization
Transfection
Neoplasms
Carcinogenesis

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer. / Gupta, Rajnish A.; Tan, Jian; Krause, Wade F.; Geraci, Mark W.; Willson, Timothy M.; Dey, Sudhansu K.; DuBois, Raymond N.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 24, 21.11.2000, p. 13275-13280.

Research output: Contribution to journalArticle

Gupta, Rajnish A. ; Tan, Jian ; Krause, Wade F. ; Geraci, Mark W. ; Willson, Timothy M. ; Dey, Sudhansu K. ; DuBois, Raymond N. / Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer. In: Proceedings of the National Academy of Sciences of the United States of America. 2000 ; Vol. 97, No. 24. pp. 13275-13280.
@article{6aa377ff0e9444f1b54f9eaf7e71622a,
title = "Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer",
abstract = "There is evidence from both genetic and pharmacologic studies to suggest that the cyclooxygenase-2 (COX-2) enzyme plays a causal role in the development of colorectal cancer. However, little is known about the identity or role of the eicosanoid receptor pathways activated by COX-derived prostaglandins (PG). We previously have reported that COX-2-derived prostacyclin promotes embryo implantation in the mouse uterus via activation of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) δ. In light of the recent finding that PPARδ is a target of β-catenin transactivation, it is important to determine whether this signaling pathway is operative during the development of colorectal cancer. Analysis of PPARδ mRNA in matched normal and tumor samples revealed that expression of PPARδ, similar to COX-2, is up-regulated in colorectal carcinomas. In situ hybridization studies demonstrate that PPARδ is expressed in normal colon and localized to the epithelial cells at the very tips of the mucosal glands. In contrast, expression of PPARδ mRNA in colorectal tumors was more widespread with increased levels in transformed epithelial cells. Analysis of PPARδ and COX-2 mRNA in serial sections suggested they were colocalized to the same region within a tumor. Finally, transient transfection assays established that endogenously synthesized prostacyclin (PGI2) could serve as a ligand for PPARδ. In addition, the stable PGI2 analog, carbaprostacyclin, and a synthetic PPARδ agonist induced transactivation of endogenous PPARδ in human colon carcinoma cells. We conclude from these observations that PPARδ, similar to COX-2, is aberrantly expressed in colorectal tumors and that endogenous PPARδ is transcriptionally responsive to PGI2. However, the functional consequence of PPARδ activation in colon carcinogenesis still needs to be determined.",
author = "Gupta, {Rajnish A.} and Jian Tan and Krause, {Wade F.} and Geraci, {Mark W.} and Willson, {Timothy M.} and Dey, {Sudhansu K.} and DuBois, {Raymond N.}",
year = "2000",
month = "11",
day = "21",
doi = "10.1073/pnas.97.24.13275",
language = "English (US)",
volume = "97",
pages = "13275--13280",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "24",

}

TY - JOUR

T1 - Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer

AU - Gupta, Rajnish A.

AU - Tan, Jian

AU - Krause, Wade F.

AU - Geraci, Mark W.

AU - Willson, Timothy M.

AU - Dey, Sudhansu K.

AU - DuBois, Raymond N.

PY - 2000/11/21

Y1 - 2000/11/21

N2 - There is evidence from both genetic and pharmacologic studies to suggest that the cyclooxygenase-2 (COX-2) enzyme plays a causal role in the development of colorectal cancer. However, little is known about the identity or role of the eicosanoid receptor pathways activated by COX-derived prostaglandins (PG). We previously have reported that COX-2-derived prostacyclin promotes embryo implantation in the mouse uterus via activation of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) δ. In light of the recent finding that PPARδ is a target of β-catenin transactivation, it is important to determine whether this signaling pathway is operative during the development of colorectal cancer. Analysis of PPARδ mRNA in matched normal and tumor samples revealed that expression of PPARδ, similar to COX-2, is up-regulated in colorectal carcinomas. In situ hybridization studies demonstrate that PPARδ is expressed in normal colon and localized to the epithelial cells at the very tips of the mucosal glands. In contrast, expression of PPARδ mRNA in colorectal tumors was more widespread with increased levels in transformed epithelial cells. Analysis of PPARδ and COX-2 mRNA in serial sections suggested they were colocalized to the same region within a tumor. Finally, transient transfection assays established that endogenously synthesized prostacyclin (PGI2) could serve as a ligand for PPARδ. In addition, the stable PGI2 analog, carbaprostacyclin, and a synthetic PPARδ agonist induced transactivation of endogenous PPARδ in human colon carcinoma cells. We conclude from these observations that PPARδ, similar to COX-2, is aberrantly expressed in colorectal tumors and that endogenous PPARδ is transcriptionally responsive to PGI2. However, the functional consequence of PPARδ activation in colon carcinogenesis still needs to be determined.

AB - There is evidence from both genetic and pharmacologic studies to suggest that the cyclooxygenase-2 (COX-2) enzyme plays a causal role in the development of colorectal cancer. However, little is known about the identity or role of the eicosanoid receptor pathways activated by COX-derived prostaglandins (PG). We previously have reported that COX-2-derived prostacyclin promotes embryo implantation in the mouse uterus via activation of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) δ. In light of the recent finding that PPARδ is a target of β-catenin transactivation, it is important to determine whether this signaling pathway is operative during the development of colorectal cancer. Analysis of PPARδ mRNA in matched normal and tumor samples revealed that expression of PPARδ, similar to COX-2, is up-regulated in colorectal carcinomas. In situ hybridization studies demonstrate that PPARδ is expressed in normal colon and localized to the epithelial cells at the very tips of the mucosal glands. In contrast, expression of PPARδ mRNA in colorectal tumors was more widespread with increased levels in transformed epithelial cells. Analysis of PPARδ and COX-2 mRNA in serial sections suggested they were colocalized to the same region within a tumor. Finally, transient transfection assays established that endogenously synthesized prostacyclin (PGI2) could serve as a ligand for PPARδ. In addition, the stable PGI2 analog, carbaprostacyclin, and a synthetic PPARδ agonist induced transactivation of endogenous PPARδ in human colon carcinoma cells. We conclude from these observations that PPARδ, similar to COX-2, is aberrantly expressed in colorectal tumors and that endogenous PPARδ is transcriptionally responsive to PGI2. However, the functional consequence of PPARδ activation in colon carcinogenesis still needs to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0034700110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034700110&partnerID=8YFLogxK

U2 - 10.1073/pnas.97.24.13275

DO - 10.1073/pnas.97.24.13275

M3 - Article

VL - 97

SP - 13275

EP - 13280

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 24

ER -